Generation of glyceraldehyde-derived advanced glycation end-products in pancreatic cancer cells and the potential of tumor promotion

Figure 5 Analysis of the proliferation of PANC-1 cells treated with glyceraldehyde-derived advanced glycation-end products-bovine serum albumin. PANC-1 cells were treated with 10 and 20 μg/mL of non-glycated control BSA and glyceraldehyde-derived advanced glycation-end products-bovine serum albumin (GA-AGEs-BSA) to then be incubated for 24 h. This assay was performed for two independent experiments. One assay was performed for n = 7. Cell proliferation was assessed by the WST-8 assay. Data are shown as mean ± SD (n = 7). P values were based on the Student’s t-test. ^aP < 0.05, ^bP < 0.01 vs control.